Subscribe To
Opiant pharma starts dosing in opnt002 mid-stage study for alcohol use disorder
Opiant pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first patient in Phase 2 trial of OPNT002, n...
January 21, 2022, 5:56 am
Opiant pharma starts dosing in opnt002 mid-stage study for alcohol use disorder
Opiant pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first patient in Phase 2 trial of OPNT002, n...
January 21, 2022, 5:56 am
Adamis pharmaceuticals: market continues to overlook tempol's potential to be a leading covid-19 therapeutic
Adamis pharmaceuticals is moving TEMPOL forward against COVID-19. The FDA recently announced that they ...
January 20, 2022, 12:20 pm
Adamis pharmaceuticals: market continues to overlook tempol's potential to be a leading covid-19 therapeutic
Adamis pharmaceuticals is moving TEMPOL forward against COVID-19. The FDA recently announced that they ...
January 20, 2022, 12:20 pm
Adamis pharmaceuticals: market continues to overlook tempol's potential to be a leading covid-19 therapeutic
Adamis pharmaceuticals is moving TEMPOL forward against COVID-19. The FDA recently announced that they ...
January 20, 2022, 12:20 pm
Is cns pharmaceuticals, inc. (cnsp) outperforming other medical stocks this year?
Here is how CNS pharmaceuticals, Inc. (CNSP) and Celyad SA (CYAD) have performed compared to their sect...
January 20, 2022, 10:45 am
Is cns pharmaceuticals, inc. (cnsp) outperforming other medical stocks this year?
Here is how CNS pharmaceuticals, Inc. (CNSP) and Celyad SA (CYAD) have performed compared to their sect...
January 20, 2022, 10:45 am
Is cns pharmaceuticals, inc. (cnsp) outperforming other medical stocks this year?
Here is how CNS pharmaceuticals, Inc. (CNSP) and Celyad SA (CYAD) have performed compared to their sect...
January 20, 2022, 10:45 am
Cns pharmaceuticals to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"...
January 20, 2022, 8:45 am
Cns pharmaceuticals to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"...
January 20, 2022, 8:45 am
Cns pharmaceuticals to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"...
January 20, 2022, 8:45 am
Moleculin biotech, inc. to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage ...
January 20, 2022, 8:40 am
Moleculin biotech, inc. to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage ...
January 20, 2022, 8:40 am
Moleculin biotech, inc. to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage ...
January 20, 2022, 8:40 am
Vallon pharmaceuticals to present at the virtual investor 2022 top picks conference
– Liv e video webcast presentation on Tuesday, January 25 th at 9:00 AM ET...
January 20, 2022, 8:35 am
Vallon pharmaceuticals to present at the virtual investor 2022 top picks conference
– Liv e video webcast presentation on Tuesday, January 25 th at 9:00 AM ET...
January 20, 2022, 8:35 am
Vallon pharmaceuticals to present at the virtual investor 2022 top picks conference
– Liv e video webcast presentation on Tuesday, January 25 th at 9:00 AM ET...
January 20, 2022, 8:35 am
Phathom pharmaceuticals: undiscovered gem
Phathom pharmaceuticals: Undiscovered Gem...
January 20, 2022, 1:00 am
Phathom pharmaceuticals: undiscovered gem
Phathom pharmaceuticals: Undiscovered Gem...
January 20, 2022, 1:00 am
Phathom pharmaceuticals: undiscovered gem
Phathom pharmaceuticals: Undiscovered Gem...
January 20, 2022, 1:00 am